Continue to site >
Trending ETFs

Name

As of 03/26/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$30.52

$1.48 B

2.06%

$0.63

0.97%

Vitals

YTD Return

11.6%

1 yr return

32.3%

3 Yr Avg Return

4.8%

5 Yr Avg Return

10.3%

Net Assets

$1.48 B

Holdings in Top 10

68.6%

52 WEEK LOW AND HIGH

$30.3
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 0.97%

SALES FEES

Front Load 5.75%

Deferred Load N/A

TRADING FEES

Turnover 72.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$0

IRA

$500


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 03/26/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$30.52

$1.48 B

2.06%

$0.63

0.97%

FBTAX - Profile

Distributions

  • YTD Total Return 11.6%
  • 3 Yr Annualized Total Return 4.8%
  • 5 Yr Annualized Total Return 10.3%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 0.20%
DIVIDENDS
  • Dividend Yield 2.1%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Fidelity Advisor Biotechnology Fund
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Jan 12, 2001
  • Shares Outstanding
    N/A
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Eirene Kontopoulos

Fund Description

Normally investing primarily in common stocks.Normally investing at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology.Investing in domestic and foreign issuers.Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Read More

FBTAX - Performance

Return Ranking - Trailing

Period FBTAX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.6% -15.0% 17.3% 4.91%
1 Yr 32.3% -20.2% 35.0% 3.68%
3 Yr 4.8%* -30.8% 14.0% 36.54%
5 Yr 10.3%* -3.5% 14.3% 25.00%
10 Yr 9.0%* 0.2% 14.1% 57.94%

* Annualized

Return Ranking - Calendar

Period FBTAX Return Category Return Low Category Return High Rank in Category (%)
2023 9.3% -12.6% 19.0% 12.88%
2022 -7.9% -53.9% 3.2% 21.15%
2021 -19.9% -39.6% 24.2% 85.90%
2020 22.1% -13.6% 178.2% 20.53%
2019 17.8% 3.8% 63.8% 73.33%

Total Return Ranking - Trailing

Period FBTAX Return Category Return Low Category Return High Rank in Category (%)
YTD 11.6% -15.0% 17.3% 4.91%
1 Yr 32.3% -20.2% 35.0% 3.68%
3 Yr 4.8%* -30.8% 14.0% 36.54%
5 Yr 10.3%* -3.5% 14.3% 25.00%
10 Yr 9.0%* 0.2% 14.1% 57.94%

* Annualized

Total Return Ranking - Calendar

Period FBTAX Return Category Return Low Category Return High Rank in Category (%)
2023 10.7% -12.6% 19.0% 14.72%
2022 -7.9% -53.9% 3.7% 33.97%
2021 -3.6% -33.9% 26.0% 82.69%
2020 32.2% -0.7% 180.6% 25.83%
2019 25.7% 4.6% 63.8% 51.11%

NAV & Total Return History


FBTAX - Holdings

Concentration Analysis

FBTAX Category Low Category High FBTAX % Rank
Net Assets 1.48 B 6.16 M 45 B 31.29%
Number of Holdings 95 23 413 39.88%
Net Assets in Top 10 935 M 2.07 M 20.4 B 21.47%
Weighting of Top 10 68.63% 18.1% 77.0% 5.52%

Top 10 Holdings

  1. ABBVIE INC 24.01%
  2. REGENERON PHARMACEUTICALS INC 10.69%
  3. GILEAD SCIENCES INC 9.19%
  4. Fidelity Securities Lending Cash Central Fund 7.14%
  5. AMGEN INC 3.68%
  6. ASCENDIS PHARMA AS SPON ADR 3.32%
  7. ARGENX SE SPONSORED ADR 3.06%
  8. ALNYLAM PHARMACEUTICALS INC 2.83%
  9. KARUNA THERAPEUTICS INC 2.42%
  10. CELLDEX THERAPEUTICS INC 2.30%

Asset Allocation

Weighting Return Low Return High FBTAX % Rank
Stocks
94.40% 87.17% 106.13% 74.85%
Cash
8.54% 0.00% 32.99% 12.88%
Preferred Stocks
2.47% 0.00% 7.86% 7.98%
Other
0.00% -22.99% 17.73% 44.79%
Convertible Bonds
0.00% 0.00% 0.37% 20.25%
Bonds
0.00% 0.00% 12.39% 25.15%

Stock Sector Breakdown

Weighting Return Low Return High FBTAX % Rank
Healthcare
100.00% 59.26% 100.00% 8.86%
Utilities
0.00% 0.00% 0.00% 13.29%
Technology
0.00% 0.00% 22.69% 20.25%
Real Estate
0.00% 0.00% 5.89% 17.09%
Industrials
0.00% 0.00% 7.02% 18.99%
Financial Services
0.00% 0.00% 1.60% 37.97%
Energy
0.00% 0.00% 0.00% 13.29%
Communication Services
0.00% 0.00% 9.11% 16.46%
Consumer Defense
0.00% 0.00% 25.73% 23.42%
Consumer Cyclical
0.00% 0.00% 1.92% 18.99%
Basic Materials
0.00% 0.00% 7.16% 43.04%

Stock Geographic Breakdown

Weighting Return Low Return High FBTAX % Rank
US
94.40% 66.21% 104.41% 36.81%
Non US
0.00% 0.00% 29.78% 61.35%

FBTAX - Expenses

Operational Fees

FBTAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.97% 0.08% 4.28% 57.06%
Management Fee 0.71% 0.03% 1.25% 54.60%
12b-1 Fee 0.25% 0.00% 1.00% 29.49%
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

FBTAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.75% 3.50% 5.75% 20.83%
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

FBTAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% 80.49%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBTAX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 72.00% 0.00% 238.00% 84.78%

FBTAX - Distributions

Dividend Yield Analysis

FBTAX Category Low Category High FBTAX % Rank
Dividend Yield 2.06% 0.00% 6.95% 24.54%

Dividend Distribution Analysis

FBTAX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual Monthly Annual

Net Income Ratio Analysis

FBTAX Category Low Category High FBTAX % Rank
Net Income Ratio 0.20% -2.54% 1.85% 26.28%

Capital Gain Distribution Analysis

FBTAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Annually Annually

Distributions History

View More +

FBTAX - Fund Manager Analysis

Managers

Eirene Kontopoulos


Start Date

Tenure

Tenure Rank

Jul 15, 2018

3.88

3.9%

Eirene Kontopoulos joined Fidelity Investments in 2007, she has worked as a research analyst and portfolio manager.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.84 0.25